FDA Warns ThyssenKrupp Over Wheelchair Lift Defects

Law360, New York (April 11, 2012, 6:20 PM EDT) -- A ThyssenKrupp AG unit was hit with a warning letter from the U.S. Food and Drug Administration, posted on the agency's website Tuesday, for allegedly failing to adequately address reports of product defects in the company's vertical wheelchair lifts.

The letter comes on the heels of a November inspection by the FDA of ThyssenKrupp Access Manufacturing LLC's facilities in Roanoke, Ill., which revealed violations of the FDA's good manufacturing practice requirements.

ThyssenKrupp's wheelchair lifts are defined as devices subject to government regulation under the Federal Food,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.